Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hemodialysis Complication: early-phase trial registry
1 of 4 indexed Hemodialysis Complication trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Hemodialysis Complication: 4 US clinical trials tracked, 1 recruiting.
Hemodialysis Complication is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Hamad Medical Corporation, running 1 of these trials.
Enrollment posture brief
Registry condition hemodialysis-complication
OPEN 1 | RECR 25% | LATE 0 | EARLY 1 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
Hemodialysis Complication lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hemodialysis Complication on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hemodialysis Complication is recruiting below its size-band peers.
1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
Hamad Medical Corporation
NCT05407207
The Arteriovenous Vascular (AV) ACCESS Trial
Wake Forest University Health Sciences
NCT04646226
Hemodialysis.-Induced Hypotension Therapy for End Stage Kidney Disease
Vanderbilt University Medical Center
NCT05297786
Timing of Antihypertensive Medications on Key Outcomes in Hemodialysis
Stanford University
NCT03327909
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Hemodialysis Complication records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hemodialysis Complication trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hemodialysis Complication page
4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Hemodialysis Complication trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Hamad Medical Corporation sponsors the most Hemodialysis Complication trials on record, review their full trial history before evaluating a specific study. See Hamad Medical Corporation's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hemodialysis Complication condition card totals 4 registered trials; most-linked intervention TAKE vs. HOLD; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.